1. Home
  2. SNCR vs VSTM Comparison

SNCR vs VSTM Comparison

Compare SNCR & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Synchronoss Technologies Inc.

SNCR

Synchronoss Technologies Inc.

HOLD

Current Price

$8.56

Market Cap

59.5M

Sector

Technology

ML Signal

HOLD

Logo Verastem Inc.

VSTM

Verastem Inc.

HOLD

Current Price

$7.71

Market Cap

723.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNCR
VSTM
Founded
2000
2010
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.5M
723.8M
IPO Year
2006
2012

Fundamental Metrics

Financial Performance
Metric
SNCR
VSTM
Price
$8.56
$7.71
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$13.38
AVG Volume (30 Days)
290.1K
1.7M
Earning Date
11-04-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$170,909,000.00
$13,379,000.00
Revenue This Year
N/A
$208.54
Revenue Next Year
$4.37
$251.40
P/E Ratio
N/A
N/A
Revenue Growth
0.07
33.79
52 Week Low
$3.98
$3.46
52 Week High
$12.85
$11.25

Technical Indicators

Market Signals
Indicator
SNCR
VSTM
Relative Strength Index (RSI) 74.29 37.70
Support Level $8.39 $7.59
Resistance Level $8.50 $8.14
Average True Range (ATR) 0.13 0.53
MACD -0.08 -0.14
Stochastic Oscillator 83.75 11.33

Price Performance

Historical Comparison
SNCR
VSTM

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Share on Social Networks: